Your browser doesn't support javascript.
loading
Rituximab for rapidly progressive juvenile systemic sclerosis.
Zulian, Francesco; Dal Pozzolo, Roberto; Meneghel, Alessandra; Castaldi, Biagio; Marcolongo, Renzo; Caforio, Alida Linda Patrizia; Martini, Giorgia.
Affiliation
  • Zulian F; Department of Woman's and Child's Health.
  • Dal Pozzolo R; Department of Woman's and Child's Health.
  • Meneghel A; Department of Woman's and Child's Health.
  • Castaldi B; Department of Woman's and Child's Health.
  • Marcolongo R; Clinical Immunology, Department of Medicine.
  • Caforio ALP; Department of Cardiological, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Martini G; Department of Woman's and Child's Health.
Rheumatology (Oxford) ; 59(12): 3793-3797, 2020 Dec 01.
Article in En | MEDLINE | ID: mdl-32442284

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Antirheumatic Agents / Rituximab Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2020 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Antirheumatic Agents / Rituximab Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2020 Document type: Article Country of publication: Reino Unido